$CYDY Selling Compassionate Use Leronlimab may bring in massive revenue. It's a way for nations to get around the need for EUA or similar lengthy approvals. Example, the Philippines issued a blanket allowance for each of their over 1000 hospitals, to order and stock enough Leronlimab for 100 patients, no EUA needed, this is CSP. India may/should follow this strategy.....considering the need is "immediate" for "asap" distribution, as Macleods stated in today's PR.